Search results
Showing 1741 to 1755 of 8910 results
Talacotuzumab for untreated acute myeloid leukaemia [ID1262]
In development Reference number: GID-TA10249 Expected publication date: TBC
Avelumab for untreated PD-L1 positive recurrent or metastatic non-small-cell lung cancer [ID1261]
In development Reference number: GID-TA10250 Expected publication date: TBC
Doxorubicin nanoparticles for previously treated advanced hepatocellular carcinoma [ID1314]
In development Reference number: GID-TA10251 Expected publication date: TBC
Managing common infections - antimicrobial prescribing guidelines
In development Reference number: GID-NG10050 Expected publication date: TBC
Epilepsies in children, young people and adults (extraordinary review)
In development Reference number: GID-NG10378 Expected publication date: TBC
Bipolar disorder: assessment and management (extraordinary review)
In development Reference number: GID-NG10380 Expected publication date: TBC
Awaiting development Reference number: GID-QS10147 Expected publication date: TBC
Awaiting development Reference number: GID-QS10148 Expected publication date: TBC
Awaiting development Reference number: GID-QS10149 Expected publication date: TBC
In development Reference number: GID-QS10177 Expected publication date: TBC
In development Reference number: GID-TA10046 Expected publication date: 22 November 2017
Regorafenib for treating advanced gastrointestinal stromal tumours [ID1056]
In development Reference number: GID-TA10089 Expected publication date: 15 November 2017
Awaiting development Reference number: GID-QS10035 Expected publication date: TBC
Awaiting development Reference number: GID-QS10036 Expected publication date: TBC
Awaiting development Reference number: GID-QS10038 Expected publication date: TBC